摘要
目的观察降脂片治疗高脂血症的临床疗效及安全性。方法 117例高脂血症患者随机分为3组,治疗组39例采用降脂片治疗,对照组A 41例采用脂必妥片治疗,对照组B 37例采用洛伐他汀片治疗。4周为1个疗程。结果治疗组和两对照组的临床总有效率无显著性差异(P﹥0.05)。治疗后,血胆固醇和甘油三酯都有显著性降低,治疗组与两对照组在降幅方面有显著性差异(P<0.05)。结论降脂片治疗高脂血症有良好效果,且不良反应较少,安全性高。
Objective To observe the clinical efficacy and safety of Jiangzhi tablet in the treatment of hyperlipoidemia. Meth- ods 117 patients of hyperlipoidemia were randomly divided into 3 groups. Treatment group （39 patients） were treated with Jiangzhi tablet and control group A （41 patients） were treated with Zbibituo tablet, and control group B （37 patients） were treated with lovastatin tablet. The course of treatment was 4 weeks. Results There was no significant difference between treatment group and two control groups in the total effective rate （ P 〉 0.05 ）. The level of the total cholesterol and triglycerides in blood were decreased obviously in three groups after treatment （P 〈 0.05）. There was significant difference between treatment group and two control groups in decreasing range （P 〈 0. 05）. Conclusion Jiangzhi tablet had significant effect on hyperlipoidemia with low side effect of toxicity and high safety.
出处
《药学实践杂志》
CAS
2013年第1期51-52,63,共3页
Journal of Pharmaceutical Practice
关键词
降脂片
高脂血症
脂必妥
洛伐他汀
Jiangzhi tablet
hyperlipidemia
Zhibituo
lovastatin
